Molecular Partners Ag (MOLN) Other Non Operating Income (2020 - 2025)
Molecular Partners Ag (MOLN) posted quarterly Other Non Operating Income of -$188766.5 for Q3 2025, up 93.52% year-on-year from -$97543.5 in Q3 2024, and up 84.9% on a QoQ basis from -$1.3 million in Q1 2025.
Molecular Partners Ag (MOLN) Other Non Operating Income (2020 - 2025) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Other Non Operating Income for 4 consecutive years, with -$188766.5 the latest figure, recorded in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Molecular Partners Ag | 147.97 Mn | 147.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -188,766.54 |
| Mar 31, 2025 | -1.25 Mn |
| Sep 30, 2024 | -2.91 Mn |
| Mar 31, 2023 | -589,233.60 |
| Sep 30, 2020 | -1.37 Mn |